Common mechanism for the estrogen agonist and antagonist activities of droloxifene

Journal of Cellular Biochemistry

Volumn 65, Issue 2, 1997, Pages 159-171

  Grasser, W A ^a   Pan, L C ^a   Thompson, D D ^a   Paralkar, V M ^a  

^a PFIZER INC   (United States)

Author keywords

apoptosis; breast cancer; droloxifene; estrogen replacement therapy; osteoclasts

Indexed keywords

ANTIESTROGEN; CALCITONIN; CALCITRIOL; DROLOXIFENE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; PROTEIN P53;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN ACTIVITY; FEMALE; GROWTH INHIBITION; HUMAN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BONE MARROW; BONE MARROW CELLS; BREAST NEOPLASMS; CELL COUNT; CELL DIVISION; CELLS, CULTURED; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; GENE EXPRESSION; GENES, P53; HUMANS; INTEGRIN BETA3; OSTEOCLASTS; OVARIECTOMY; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN; TUMOR CELLS, CULTURED;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0030959426     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199705)65:2<159::AID-JCB3>3.0.CO;2-T     Document Type: Article

References (34)

1. Athanasou NA, Alvarez JI, Ross FP, Quinn JM, Teitelbaum SL (1992): Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes. Calcif Tissue Int 50:427-432.
2. Chen HK, Ke HZ, Jee WSS, Ma YF, Pirie CM, Simmons HA, Thompson DD (1995): Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: A dual-energy x-ray absorptiometric and histomorphometric study. J Bone Min Res. 10:1256-1262.
3. Chen H, Tritton TR, Kenny N, Absher M, Chiu JF (1996): Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J Cell Biol 61(1):9-17.
4. Eppenberger U, Wosikowski K, Kung W (1991): Pharmacologie and biologic properties of droloxifene, a new antiestrogen. Am J Clin Oncol 4:S5-S13.
5. Ericksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988): Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86.
6. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Manolagas SL (1992): 17β-estradiol inhibits interleukin-6 production by bone marrow derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
7. Hata K, Kukita T, Akamine A, Kukita A, Kurisu K (1992): Trypsinized osteoclast-like multinucleated cells formed rat bone marrow cultures efficiently from resorption lacunae on dentine. Bone 13:139-146.
8. Helfrich MH, Nesbitt SA, Horton MA (1992): Integrins on rat osteoclasts: Characterization of two monoclonal antibodies (F4 and F11) to rat beta 3. J Bone Miner Res 7:345-351.
9. Hughes DE, Jilka R, Manolagas S, Dallas LS, Bonewald LF, Mundy GR, Boyce BF (1995): Sex steroids promote osteoclast apoptosis in vitro and in vivo. J Bone Min Res 10(Suppl.1):S150.
10. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagos SL (1992): Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257:88-91.
11. Kalu DN (1991): The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-192.
12. Kalu DN, Salerno E, Liu CC, Echon R, Ray M, Garza-Zapata M, Hollis BW (1991): A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat. Bone Miner 15:109-123.
13. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD (1995): Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology 136:2435-2441.
14. Kerr JFR, Winterford CM, Harmon BV (1994): Apotosis its significance in cancer and cancer therapy. Cancer 73: 2013-2026.
15. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Hausler MR (1988): Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 241:81-83.
16. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B (1995): The biochemistry of cell programmed death. FASEB J 9:1277-1287.
17. Lindsay R (1991): Why do oestrogens prevent bone loss? Builliere's Clinical Obstetrics and Gynaecology 5:837-852.
18. Lobo RA (1995): Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 173:982-989.
19. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 80:425-429.
20. Metz T, Harris AW, Adams JM (1995): Absence of p53 allows direct immortalization of hematopoetic cells by the myc and raf oncogenes. Cell 82:29-36.
21. Neter J, Wasserman W, Whitmore GA (1982): "Applied Statistics." Boston, MA: Allyn and Bacon.
22. Oren M (1994): Relationship of p53 to the control of apoptotic cell death. Cancer Biol 5:221-227.
23. Paganini-Hill A, Henderson VW (1994): Estrogen deficiency and risk of Alzheimer's disease. Am J Epidemiol 140:256-261.
24. Riggs BL, Melton III LJ (1992): The prevention and treatment of osteoporosis. N Engl J Med 327:620-627.
25. Roos W, Oeze L, Loser R, Eppenberger U (1983): Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7. J Nat Can Inst 71:55-59.
26. Sato M, Grasser W (1990): Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Min Res 5:31-40.
27. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells. Endocrinology 123:1504-1510.
28. Takahashi N, Akatsu T, Udagawa N, Sasaki Y, Yamaguchi A, Moseley JM, Martin TJ, Suda T (1988b): Osteoblast cells are involved in osteoclast formation. Endocrinology 123:2600-2602.
29. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyd A, Suda T (1988c): Osteoclast-like cell formation and its regulation by osteotrophic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1381.
30. Taylor IW (1980): A rapid single step staining technique for DNA analysis by flow cytometry. J Histo Cyto 28:1021-1024.
31. Turner RT, Riggs BL, Spelsberg TC (1994): Skeletal effects of estrogen. Endocrine Rev 15:275-300.
32. Wronski TJ, Dann LM, Scott KS, Cintron M (1989): Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45:360-366.
33. Wyllie AH (1980): Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
34. Yang NN, Venugopalan M, Hardikar S, Glasebrook A (1996): Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222-1225.